All data are based on the daily closing price as of September 6, 2024
h
Hanmi Pharmaceutical
008930.KO
24.58 USD
1.40
+6.04%
Overview
Last close
24.58 usd
Market cap
1.66B usd
52 week high
41.97 usd
52 week low
19.60 usd
Target price
24.21 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.7401
Price/Book Value
2.6567
Enterprise Value
1.78B usd
EV/Revenue
1.8768
EV/EBITDA
15.3981
Key financials
Revenue TTM
950.10M usd
Gross Profit TTM
98.03M usd
EBITDA TTM
43.74M usd
Earnings per Share
N/A usd
Dividend
0.22 usd
Total assets
1,267.32B usd
Net debt
N/A usd
About
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.